Physician profile
Mark J Fuoss
NPI 1174539241
$813.16
in general payments reported to CMS, 2019-2025
21 companies · $14.65 in 2025
The $14.65 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $158 · 2023: $35.01 · 2024: $59.11 · 2025: $14.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $124.06 | 2019 | |
| Therapeuticsmd, INC. | $94.46 | 2019 | |
| Abbvie INC. | $83.85 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $59.36 | 2019-2020 | |
| Astellas Pharma US INC | $55.61 | 2019-2020 | |
| Amgen INC. | $52.87 | 2019-2024 | Prolia, Evenity |
| Vertical Pharmaceuticals, LLC | $49.17 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $43.04 | 2019-2020 | |
| Pfizer INC. | $38.70 | 2019-2024 | |
| Organon LLC | $31.97 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $31.89 | 2019-2023 | |
| Allergan, INC. | $22.91 | 2019 | |
| Pharmacosmos Therapeutics INC. | $19.06 | 2020 | |
| Hologic Sales and Service, LLC | $16.85 | 2019 | |
| Exeltis, USA INC. | $13.61 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $13.56 | 2019 | |
| Mission Pharmacal Company | $13.34 | 2020 | |
| Merck Sharp & Dohme LLC | $13.05 | 2019 | |
| Avion Pharmaceuticals | $12.21 | 2019 | |
| Assertio Therapeutics, INC. | $12.02 | 2019 | |
| Lupin INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fuoss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.